Cargando…

Author Correction: EPO does not promote interaction between the erythropoietin and beta-common receptors

Detalles Bibliográficos
Autores principales:	Cheung Tung Shing, Karen S., Broughton, Sophie E., Nero, Tracy L., Gillinder, Kevin, Ilsley, Melissa D., Ramshaw, Hayley, Lopez, Angel F., Griffin, Michael D. W., Parker, Michael W., Perkins, Andrew C., Dhagat, Urmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527692/ https://www.ncbi.nlm.nih.gov/pubmed/31110193 http://dx.doi.org/10.1038/s41598-019-43988-9

Ejemplares similares

EPO does not promote interaction between the erythropoietin and beta-common receptors
por: Cheung Tung Shing, Karen S., et al.
Publicado: (2018)

Author Index EPOS, 2015, France
Publicado: (2015)

Author Correction: Erythropoietin (EPO) haplotype associated with all-cause mortality in a cohort of Italian patients with Type-2 Diabetes
por: Montesanto, Alberto, et al.
Publicado: (2020)

Author Index EPOS, 2016, Rome, Italy
Publicado: (2016)

Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis
por: Vočanec, Danijela, et al.
Publicado: (2018)

Erythropoietin (EPO) in acute kidney injury
por: Moore, Elizabeth, et al.
Publicado: (2011)

Regulation of Erythropoietin Receptor Activity in Endothelial Cells by Different Erythropoietin (EPO) Derivatives: An in Vitro Study
por: Trincavelli, Maria Letizia, et al.
Publicado: (2013)

Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis
por: Hardee, M E, et al.
Publicado: (2005)

A dual role for the N-terminal domain of the IL-3 receptor in cell signalling
por: Broughton, Sophie E., et al.
Publicado: (2018)

Comparison of Neurite Outgrowth Induced by Erythropoietin (EPO) and Carbamylated Erythropoietin (CEPO) in Hippocampal Neural Progenitor Cells
por: Oh, Dong Hoon, et al.
Publicado: (2012)

Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
por: Soliz, Jorge, et al.
Publicado: (2020)

Author Correction: Thermodynamic Signatures of Weyl Fermions in NbP
por: Modic, K. A., et al.
Publicado: (2020)

The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia
por: Landau, Daniel, et al.
Publicado: (2018)

Corrupted DNA-binding specificity and ectopic transcription underpin dominant neomorphic mutations in KLF/SP transcription factors
por: Ilsley, Melissa D., et al.
Publicado: (2019)

Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts
por: Tankiewicz-Kwedlo, A., et al.
Publicado: (2016)

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
por: Våtsveen, Thea Kristin, et al.
Publicado: (2016)

Structural Identification of Modified Amino Acids on the Interface between EPO and Its Receptor from EPO BRP, Human Recombinant Erythropoietin by LC/MS Analysis
por: Song, Kwang-Eun, et al.
Publicado: (2014)

Huh-7 cell line as an alternative cultural model for the production of human like erythropoietin (EPO)
por: Kausar, Humera, et al.
Publicado: (2011)

Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes
por: Vetro, Calogero, et al.
Publicado: (2022)

Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
por: Awida, Zamzam, et al.
Publicado: (2022)

Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration
por: Wang, Guan, et al.
Publicado: (2017)

r.hu-Erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline
por: Tapolyai, Mihály, et al.
Publicado: (2003)

Comparative Study of Recombinant Human Erythropoietin (rhEPO) Products on CKD (Chronic Kidney Disease) Patients
por: Dwitanto, Kuspuji, et al.
Publicado: (2023)

Krüppel-like factors compete for promoters and enhancers to fine-tune transcription
por: Ilsley, Melissa D., et al.
Publicado: (2017)

Direct targets of pSTAT5 signalling in erythropoiesis
por: Gillinder, Kevin R., et al.
Publicado: (2017)

Authors’ reply
por: Khan, Nagina, et al.
Publicado: (2022)

The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know?
por: Lamon, Séverine, et al.
Publicado: (2013)

Erythropoietin (EPO) haplotype associated with all-cause mortality in a cohort of Italian patients with Type-2 Diabetes
por: Montesano, Alberto, et al.
Publicado: (2019)

Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021)

Author Correction: Inversions of landslide strength as a proxy for subsurface weathering
por: Alberti, Stefano, et al.
Publicado: (2023)

Generation of transgenic chickens expressing the human erythropoietin (hEPO) gene in an oviduct-specific manner: Production of transgenic chicken eggs containing human erythropoietin in egg whites
por: Kwon, Mo Sun, et al.
Publicado: (2018)

Methylation impact analysis of erythropoietin (EPO) Gene to hypoxia inducible factor-1α (HIF-1α) activity
por: Dewi, Firli Rahmah Primula, et al.
Publicado: (2013)

Effect of Roxadustat versus erythropoietin (EPO) for treating anemia in patients with diabetic kidney disease: a retrospective cohort study
por: Zhang, Lei, et al.
Publicado: (2022)

Author Correction: Randomised feasibility study of prehospital recognition and antibiotics for emergency patients with sepsis (PhRASe)
por: Jones, Jenna, et al.
Publicado: (2022)

ASO Author Reflections: 30 Years of Esophagectomy
por: Phillips, A. W., et al.
Publicado: (2021)

Author Correction: Hemodynamic and morphological changes of the central retinal artery in myopic eyes
por: Zhao, Mei, et al.
Publicado: (2022)

Author Directory
Publicado: (2013)

Author Index
Publicado: (2013)

Safety and Short-term Outcomes of High-Dose Erythropoietin in Preterm Infants With Intraventricular Hemorrhage: The EpoRepair Randomized Clinical Trial
por: Wellmann, Sven, et al.
Publicado: (2022)

EPOS Abstract Book
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1pv31374kqqb13iflljd79oaqh